Navigation Links
The Coming of Biotech Generic Pharmaceuticals

CHICAGO In a column last year, I commented on the growing generic pharmaceuticals business in the U.S. and around the world. Generic pharmaceuticals are not only big business but will continue to get even bigger. There are a couple reasons why:

1) Numerous drug patents expiring over the next couple years.

2) The increased concern in the U.S. about rising drug pri......

Full article >>> s).

Second, the actual final manufacturing isnt easy and requires special care. Most of these products are injectables as few if any protein-based drugs can be administered orally. They do not successfully survive the transition through the stomach in order to release a therapeutic effect in the gastrointestinal tract.

So what is at stake here? The answer is a lot! Biotech drug......

Full article >>> t, most cancers are still incurable and only a few types of cancer (testicular cancer and some types of leukemias) are curable. Existing therapy only has marginal effect. There is plenty of room here for therapeutic improvement particularly considering there are more than 1 million new cases of cancer in the U.S. alone each year.

2) The FDA has recognized this dilemma and has prov......

Full article >>>

Unfortunately, the NCI today is a very large bureaucracy whose goal is the discovery and development of new therapies but not the commercialization of such therapy. As such, the NCI process is very slow.



Given the NCIs role in developing and funding the early stage development of many cancer drugs and the governments concern about the rising cost of medicines, it is ......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 01/26/04


Related biology technology :

1. Social engineering - Coming to an IT ship near you?
2. Biotech officials praise focus of new venture fund
3. Biotech executive books a career flight thats closer to home
4. Gala Biotech among companies sold for $3.3 billion
5. Biotech with Madison ties raises $21M in capital
6. Biotech firm uses live heart tissue in drug screens
7. Biotech talent drew venture-funded firm to Madison
8. Biotech firm has strokes, Alzheimers in its sights
9. 42 days until the 2006 Olympics of Biotechnology in Chicago
10. Biotech crops gaining acceptance, but their full promise has yet to be fulfilled
11. Biotech leads list of top U.S. companies to work for
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... ... 23, 2016 , ... UAS LifeSciences, one of the leading ... UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing high ... its list of well-respected retailers. This list includes such fine stores as Whole ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology:
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
Breaking Biology News(10 mins):